Company Profile
Atossa Therapeutics, Inc. Stock Price, News & Analysis
- Ticker:
- ATOS
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
2.42 USD (+2.33%)
Close
Last updated: July 28, 2026
41.8M USD
Market cap
Why the stock is moving
As of Jul 28, 2026, ATOS closed up 2.33% at $2.42. No new same-company headline was identified in the current news window.
Company overview
Business overview
Atossa Therapeutics is a breast-cancer company focused on therapies and diagnostics in oncology and women’s health. Its business is centered on targeted disease biology and cancer-related development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Atossa sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on clinical data, biomarker strategy, and the ability to create a focused breast-cancer story.
Position Within the Biotechnology Landscape
Atossa is a catalyst-sensitive oncology name whose valuation is driven by data and differentiation.
Future catalysts
Atossa’s catalysts are endoxifen and any breast-cancer development progress that keeps the selective-estrogen-receptor story alive. The next update matters because the company still needs stronger human evidence.
Recent news
- 01
Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
Source: Atossa Therapeutics, Inc.
- 02
- 03
- 04
Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
Source: Atossa Therapeutics, Inc.
- 05
Atossa Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Source: Atossa Therapeutics, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Atossa Therapeutics, Inc. (ATOS)?
Atossa Therapeutics, Inc. (ATOS) most recently closed at 2.42 USD, a +2.33% move versus the previous session.
What is the market cap of Atossa Therapeutics, Inc. (ATOS)?
Atossa Therapeutics, Inc. currently has a market capitalization of 41.8M USD on BioPharmSignal.
What does Atossa Therapeutics, Inc. do?
Atossa Therapeutics is a breast-cancer company focused on therapies and diagnostics in oncology and women’s health. Its business is centered on targeted disease biology and cancer-related development.
On which exchange is ATOS stock listed?
Atossa Therapeutics, Inc. (ATOS) is associated with NASDAQ, United States, MedTech.
What is Atossa?
Atossa’s catalysts are endoxifen and any breast-cancer development progress that keeps the selective-estrogen-receptor story alive.
Which conditions is Atossa Therapeutics, Inc. targeting with Atossa?
Atossa Therapeutics, Inc. is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Atossa Therapeutics, Inc. describe recent progress with Atossa?
Atossa’s catalysts are endoxifen and any breast-cancer development progress that keeps the selective-estrogen-receptor story alive.
What is Therapeutics?
Atossa Therapeutics is a breast-cancer company focused on therapies and diagnostics in oncology and women’s health.